Pages that link to "Document:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022"
From GxPlex
The following pages link to Document:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022:
Displaying 50 items.
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 2 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 4 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-001 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 5 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 6 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 7 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 8 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 9 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 10 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 11 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 12 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 13 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 14 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-002 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1 (f) (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 2-3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 2 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 3-5 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 6-8 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 34 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 2-3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 32 Paragraph 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 32 Paragraph 2-3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 33 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 2-3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section K No. 59-60 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section D No.17 ; No. 22 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX VI Section D No. 8 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX VI Section 2.5 No. 17-22 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 51 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 66 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 67 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 68 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 69 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-003 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 52 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 56 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 57 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 48 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 13 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 15 (transclusion) (← links)